3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Metastatic Solid Tumors
1
Interventions
pembrolizumab
33
Injections
28
Pemetrexed
15
Interviews as Topic
15
Carboplatin
14
tislelizumab
13
Cisplatin
13
Specimen Handling
12
Bevacizumab
11
atezolizumab
10
Nivolumab
10
Practice Guidelines as Topic
9
Educational Status
9
Cyclophosphamide
9
Standard of Care
8
Oxaliplatin
8
Fluorouracil
8
fludarabine
7
Methods
7
Early Intervention, Educational
7
Docetaxel
7
Cetuximab
7
Capecitabine
7
toripalimab
6
sotorasib
6
Paclitaxel
6
Leucovorin
6
olaparib
5
Platinum
5
Ipilimumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
bintrafusp alfa protein, human
×
Other solid neoplasm
×
90 days
×
Clear all
NCT04457778
2026-05-04
First in Human Study of M6223
EMD Serono
Phase 1
Completed
58 enrolled
38 charts